Robert Lanza Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Lanza.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Lanza. Robert Lanza is a Chief Scientfic Officer in Ocata Therapeutics, Inc. ($ACTC) and a Chief Scientific Officer in Ocata Therapeutics, Inc. ($ACTC).
Address: 33 LOCKE DRIVE MARLBOROUGH 01752 MA
Companies in which Robert Lanza is an Insider
Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Lanza: Chief Scientfic Officer, Chief Scientific Officer
Holdings: 28,529,003 shares
Latest Transaction: Jul 26 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Robert Lanza
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 26 2012 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Grant | A | 0.00 | 1,285,714 | 0 | 28,529,003 | 27.2 M to 28.5 M (+4.72 %) |
| Jul 26 2012 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Grant | A | 0.00 | 1,285,714 | 0 | 27,243,289 | 26 M to 27.2 M (+4.95 %) |
| Jan 25 2012 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 0.19 | 6,658,300 | 1,277,728 | 25,957,575 | 32.6 M to 26 M (-20.41 %) |
| Jan 25 2012 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 0.18 | 1,000,000 | 175,400 | 32,615,875 | 33.6 M to 32.6 M (-2.97 %) |
| Sep 30 2011 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 0.15 | 608,225 | 93,058 | 33,615,875 | 34.2 M to 33.6 M (-1.78 %) |
| Sep 30 2011 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 0.15 | 108,080 | 16,320 | 34,224,100 | 34.3 M to 34.2 M (-0.31 %) |
| Sep 30 2011 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | S | 0.15 | 10,000 | 1,520 | 34,332,180 | 34.3 M to 34.3 M (-0.03 %) |